U.S. stocks fell Thursday, with Wall Street pausing after a two-session win streak.» Read More
*MannKind stumbles; FDA extends drug review date. However, other names such as Facebook Inc, up 1 percent to $57.33 and Gilead Sciences Inc, up 0.8 percent at $72.76, were able to reverse initial declines.
*Mallinckrodt to buy Questcor for $5.6 bln. *MannKind stumbles; FDA extends review date for insulin treatment. *Earnings season gets under way this week, with earnings expected from financials JPMorgan Chase& Co and Wells Fargo& Co, as well as retailer Bed, Bath& Beyond.
*Mallinckrodt to buy Questcor for $5.6 bln. *MannKind stumbles; FDA extends review date for insulin treatment. *Earnings season gets under way this week, with earnings expected from financials JPMorgan Chase& Co and Wells Fargo& Co, as well as retailer Bed, Bath& Beyond expected.
Familiar names such as Netflix, Facebook and Tesla Motors, along with a number of biotechnology and cloud-computing stocks, have been pummeled in the last month. Facebook Inc, for example, has fallen nearly 22 percent from an intraday record reached less than a month ago.
Traders are watching to see if once high-flying Internet, social media and biotech names can stabilize or whether they will ensnare the broader market in a bigger downdraft.
Autozone Inc. fell $9.49 or 1.8 percent, to $526.12. Bed Bath& Beyond Inc. fell$. 58 or. 8 percent, to $69.22. Best Buy rose$. 93 or 3.5 percent, to $27.70.
Here's what Cramer will be watching and doing as earnings season gets underway in the week ahead.
Autozone Inc. fell $8.66 or 1.6 percent, to $526.95. Bed Bath& Beyond Inc. rose$. 42 or. 6 percent, to $70.21. RadioShack fell$. 01 or. 5 percent, to $2.19.
Autozone Inc. fell $3.07 or. 6 percent, to $532.54. Bed Bath& Beyond Inc. rose$. 37 or. 5 percent, to $70.17. Best Buy rose$. 09 or. 3 percent, to $26.86.
It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Some of the names on the move ahead of the open.
It might be unfathomable to people who bear scars from inflation in the 1970s, but what the global economy could use is a dose of higher prices.
Consumer discretionary stocks helped lead the way for the stock market last year, and now, they may be poised to lead to the downside as well.
Best Buy and Bed Bath & Beyond were red hot in 2013, but both have gone ice cold. CNBC's Dominic Chu and Seema Mody debate which company has a better chance of turning things around in 2014.
Investors have punished retailers so far this year, but Restoration Hardware's 15 percent stock drop may not be justified. Here's why.
Are you a hunter or gatherer? Why are tennis balls fuzzy? Prepare to be stumped—here are the top 25 oddball interview questions for 2014.
Anthony Chukumba, BB&T Capital Markets, and Brian Nagel, Oppenheimer, debate the case of Bed Bath and Beyond. Chukumba says online competition is having an impact on the company that is light years behind Amazon.
Earnings season heats up this week, and the results actually could mean something this time.
Retailers responded to weakness last year with deep discounts and promotions. Still, the softness is creeping into January.
People keep asking Cramer if anything makes him nervous about this market. Quite frankly, yes.